Autoimmune response following annual influenza vaccination in 92 apparently healthy adults

Autoimmunity Reviews

Volumn 8, Issue 2, 2008, Pages 134-138

  Toplak, N ^a   Kveder, T ^b   Trampus Bakija A ^a   Subelj V ^c   Cucnik S ^b   Avcin T ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

Author keywords

Autoantibodies; Healthy medical workers; Influenza; Vaccination

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN M; INFLUENZA VACCINE; LUPUS ANTICOAGULANT;

ADULT; AUTOIMMUNITY; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VACCINATION; MALE; NORMAL HUMAN; REVIEW; UNIVERSITY HOSPITAL;

ADULT; AUTOANTIBODIES; AUTOIMMUNITY; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; VACCINATION;

EID: 56349127522     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.07.008     Document Type: Review

References (24)

1. Molina V., and Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 38 (2005) 235-245
2. Shoenfeld Y., and Aron-Maor A. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?. J Autoimmun 14 (2000) 1-10
3. Haber P., DeStefano F., Angulo F.J., et al. Guillain-Barre syndrome following influenza vaccination. JAMA 24 (2004) 2478-2481
4. Mormile R., D'Alterio V., Treccagnoli G., and Sorrentino P. Henoch-Schonlein purpura with antiphospholipid antibodies after influenza vaccination: how fearful is it in children?. Vaccine 23 (2004) 567-568
5. Watanabe T., and Onda H. Henoch-Schonlein purpura with antiphospholipid antibodies following an influenza vaccination. Pediatr Nephrol 16 (2001) 458-459
6. Uji M., Matsushita H., and Iwata S. Microscopic polyangiitis after influenza vaccination. Intern Med 44 (2005) 892-896
7. Iyngkaran P., Limaye V., Hill C., Henderson D., Pile K.D., and Rischmueller M. Rheumatoid vasculitis following influenza vaccination. Rheumatology 7 (2003) 907-909
8. Chen R.T., Pless R., and DeStefano F. Epidemiology of autoimmune reactions induced by vaccination. Autoimmunity 16 (2001) 309-318
9. Bunn C., and Kveder T. Counterimmunoelectrophoresis and immunodiffusion for the detection of antibodies to soluble cellular antigens. In: Van Venrooij W.J., and Maini R.N. (Eds). Manual of biological markers of disease A3 (1993), Kluwer Academic Publishers, Dordrecht 1-12
10. Avčin T., Ambrožič A., Božič B., Accetto M., Kveder T., and Rozman B. Estimation of anticardiolipin antibodies, anti-beta2 glycoprotein I antibodies and lupus anticoagulant in a prospective longitudinal study of children with juvenile idiopathic arthritis. Clin Exp Rheumatol 20 (2002) 101-108
11. Stegnar M., Božič B., Petrnel P., Kveder T., Vene N., and Rozman B. Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis. Thromb Res 63 (1991) 433-443
12. Čučnik S., Ambrožič A., Božič B., Skitek M., and Kveder T. Anti-beta2- glycoprotein I ELISA: methodology, determination of cut-off values in 434 healthy Caucasians and evaluation of monoclonal antibodies as possible international standards. Clin Chem Lab Med 38 (2000) 777-783
13. Brandt J.T., Triplett D.A., Alving B., and Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 74 (1995) 1185-1190
14. Kendal A.P., Pereira M.S., and Skehel J.J. Concepts and procedures for laboratory based influenza surveillance (1982), Public Health Services, US Department of Health and Human services, Center for Disease Control and Prevention, Atlanta
15. Manuel O., Humar A., Chen M.H., et al. Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients. Am J Transplant 7 (2007) 2567-2572
16. Schaad U.B., Buhlmann U., Burger R., et al. Comparison of immunogenicity and safety of a virosome influenza vaccine with those of a subunit influenza vaccine in pediatric patients with cystic fibrosis. Antimicrob Agents Chemother 44 (2000) 1163-1167
17. Avčin T., and Toplak N. Antiphospholipid antibodies in response to infection. Curr Rheumatol Rep 9 (2007) 212-218
18. Shoenfeld Y., Blank M., Cervera R., Font J., Raschi E., and Meroni P.L. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 65 (2006) 2-6
19. Blank M., Krause I., Fridkin M., et al. Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 109 (2002) 797-804
20. Rahman F., Dahmen A., Herzog-Hauff S., Bocher W.O., Galle P.R., and Lohr H.F. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology 31 (2000) 512-517
21. Tarjan P., Sipka S., Lakos G., Kiss E., Ujj G., and Szegedi G. Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus. Scand J Rheumatol 35 (2006) 241-249
22. Abu-Shakra M., Press J., Buskila D., and Sukenik S. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenicity issues. Autoimmun Rev 6 (2007) 543-546
23. Martinuč Porobič J., Avčin T., Božič B., et al. Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine. Clin Exp Immunol 142 (2005) 377-380
24. Hogenesch H., Azcona-Olivera J., Scott-Montcrieff C., Snyder P.W., and Glickman L.T. Vaccine induced autoimmunity in the dog. Adv Vet Med 41 (1999) 733-747